(Q33658601)

28 July 2017

title

Clinical outcome to clozapine treatment in chronic psychiatric inpatients (English)

1 reference

28 July 2017

Advokat CD

1

1 reference

28 July 2017

Bertman LJ

series ordinal

2

1 reference

28 July 2017

Comaty JE Jr

series ordinal

3

1 reference

28 July 2017

publication date

1 January 1999

1 reference

Progress in Neuro-Psychopharmacology & Biological Psychiatry

28 July 2017

published in

1 reference

28 July 2017

volume

23

1 reference

28 July 2017

issue

1

1 reference

28 July 2017

page(s)

1-14

1 reference

Effectiveness of clozapine in hospitalised people with chronic neuroleptic-resistant schizophrenia

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2898%2900087-6

7 January 2021

Effects of clozapine on positive and negative symptoms in outpatients with schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2898%2900087-6

7 January 2021

Patient response and resource management: another view of clozapine treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2898%2900087-6

7 January 2021

Time to clozapine response in a standardized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2898%2900087-6

7 January 2021

Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2898%2900087-6

7 January 2021

Clinical effects of clozapine in chronic schizophrenia: response to treatment and predictors of outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2898%2900087-6

7 January 2021

Clozapine: is another view valid?

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2898%2900087-6

7 January 2021

The evolution of treatment resistance: biologic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2898%2900087-6

7 January 2021

Clinical and biologic response to clozapine in patients with schizophrenia. Crossover comparison with fluphenazine

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2898%2900087-6

7 January 2021

A comparison of clozapine and haloperidol in hospitalized patients with refractory schizophrenia. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2898%2900087-6

7 January 2021

Update on the clinical efficacy and side effects of clozapine

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2898%2900087-6

7 January 2021

18-month outcome of clozapine treatment for 100 patients in a state psychiatric hospital.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2898%2900087-6

7 January 2021

Pharmacoepidemiology of clozapine in 202 inpatients with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2898%2900087-6

7 January 2021

10.1016/S0278-5846(98)00087-6

Identifiers

DOI

1 reference

28 July 2017

1 reference